• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HDAC9基因中的单核苷酸多态性rs10248565作为非吸烟女性肺腺癌一种新的基因组畸变生物标志物。

SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.

作者信息

Lai Liang-Chuan, Tsai Mong-Hsun, Chen Pei-Chun, Chen Lee H, Hsiao Jen-Hao, Chen Shin-Kuang, Lu Tzu-Pin, Lee Jang-Ming, Hsu Chung-Ping, Hsiao Chuhsing K, Chuang Eric Y

机构信息

Graduate Institute of Physiology, National Taiwan University, Taipei, Taiwan.

出版信息

J Biomed Sci. 2014 Mar 21;21(1):24. doi: 10.1186/1423-0127-21-24.

DOI:10.1186/1423-0127-21-24
PMID:24650256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3994426/
Abstract

BACKGROUND

Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, but the overall five-year survival rate is still only 15%. Although cigarette smoking is the primary risk factor for lung cancer, only 7% of female lung cancer patients in Taiwan have a history of smoking. Since cancer results from progressive accumulation of genetic aberrations, genomic rearrangements may be early events in carcinogenesis.

RESULTS

In order to identify biomarkers of early-stage adenocarcinoma, the genome-wide DNA aberrations of 60 pairs of lung adenocarcinoma and adjacent normal lung tissue in non-smoking women were examined using Affymetrix Genome-Wide Human SNP 6.0 arrays. Common copy number variation (CNV) regions were identified by ≥30% of patients with copy number beyond 2 ± 0.5 of copy numbers for each single nucleotide polymorphism (SNP) and at least 100 continuous SNP variant loci. SNPs associated with lung adenocarcinoma were identified by McNemar's test. Loss of heterozygosity (LOH) SNPs were identified in ≥18% of patients with LOH in the locus. Aberration of SNP rs10248565 at HDAC9 in chromosome 7p21.1 was identified from concurrent analyses of CNVs, SNPs, and LOH.

CONCLUSION

The results elucidate the genetic etiology of lung adenocarcinoma by demonstrating that SNP rs10248565 may be a potential biomarker of cancer susceptibility.

摘要

背景

人们已做出诸多努力来阐明肺癌的病因并改善其治疗方法,但总体五年生存率仍仅为15%。尽管吸烟是肺癌的主要危险因素,但台湾只有7%的女性肺癌患者有吸烟史。由于癌症是由基因畸变的逐步积累导致的,基因组重排可能是致癌过程中的早期事件。

结果

为了鉴定早期腺癌的生物标志物,使用Affymetrix全基因组人类SNP 6.0芯片检测了60对非吸烟女性肺腺癌及相邻正常肺组织的全基因组DNA畸变。通过每个单核苷酸多态性(SNP)拷贝数超过2±0.5的拷贝数且至少有100个连续SNP变异位点的患者中≥30%来确定常见拷贝数变异(CNV)区域。通过McNemar检验鉴定与肺腺癌相关的SNP。在该位点杂合性缺失(LOH)≥18%的患者中鉴定出LOH SNP。通过对CNV、SNP和LOH的同步分析,在7号染色体p21.1区域的HDAC9基因座中鉴定出SNP rs10248565的畸变。

结论

结果表明SNP rs10248565可能是癌症易感性的潜在生物标志物,从而阐明了肺腺癌的遗传病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/09f487f6d605/1423-0127-21-24-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/b199b79d61c4/1423-0127-21-24-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/87f52c223870/1423-0127-21-24-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/296fbb402cc0/1423-0127-21-24-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/09f487f6d605/1423-0127-21-24-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/b199b79d61c4/1423-0127-21-24-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/87f52c223870/1423-0127-21-24-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/296fbb402cc0/1423-0127-21-24-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12f/3994426/09f487f6d605/1423-0127-21-24-4.jpg

相似文献

1
SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.HDAC9基因中的单核苷酸多态性rs10248565作为非吸烟女性肺腺癌一种新的基因组畸变生物标志物。
J Biomed Sci. 2014 Mar 21;21(1):24. doi: 10.1186/1423-0127-21-24.
2
EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women.EGFR 多态性、激素替代疗法与肺腺癌风险:从不吸烟女性全基因组关联研究分析。
Carcinogenesis. 2013 Mar;34(3):612-9. doi: 10.1093/carcin/bgs385. Epub 2012 Dec 13.
3
Genomic profiles specific to patient ethnicity in lung adenocarcinoma.肺腺癌中与患者种族相关的基因组特征。
Clin Cancer Res. 2011 Jun 1;17(11):3542-50. doi: 10.1158/1078-0432.CCR-10-2185. Epub 2011 Apr 26.
4
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.TP63 基因座 3q28 上的遗传变异与亚洲从不吸烟女性肺腺癌的风险相关。
Hum Genet. 2012 Jul;131(7):1197-203. doi: 10.1007/s00439-012-1144-8. Epub 2012 Feb 25.
5
Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.在早期非吸烟肺腺癌患者中鉴定出的寡基因种系突变。
Lung Cancer. 2014 Aug;85(2):168-74. doi: 10.1016/j.lungcan.2014.05.020. Epub 2014 Jun 4.
6
Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma.与肺腺癌基因修饰相关的调控单核苷酸多态性的鉴定。
BMC Res Notes. 2015 Mar 24;8:92. doi: 10.1186/s13104-015-1053-8.
7
Identification of genome variations in patients with lung adenocarcinoma using whole genome re‑sequencing.使用全基因组重测序技术鉴定肺腺癌患者的基因组变异。
Mol Med Rep. 2017 Dec;16(6):9464-9472. doi: 10.3892/mmr.2017.7805. Epub 2017 Oct 17.
8
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.从巴雷特食管进展为食管腺癌过程中的染色体异常及新的疾病相关区域。
Int J Cancer. 2009 Nov 15;125(10):2349-59. doi: 10.1002/ijc.24620.
9
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.由恶性胸膜间皮瘤和原发性肺腺癌组成的罕见同步碰撞肿瘤的比较基因分析。
Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0.
10
Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.与 I 期非小细胞肺癌术后复发相关的遗传变异。
Clin Cancer Res. 2014 Jun 15;20(12):3272-9. doi: 10.1158/1078-0432.CCR-13-2835. Epub 2014 Apr 15.

引用本文的文献

1
Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.使用综合生物信息学和机器学习方法鉴定肺癌的潜在生物标志物。
PLoS One. 2025 Feb 27;20(2):e0317296. doi: 10.1371/journal.pone.0317296. eCollection 2025.
2
A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis.新型 HIF1α-STIL-FOXM1 轴调控肿瘤转移。
J Biomed Sci. 2022 Apr 1;29(1):24. doi: 10.1186/s12929-022-00807-0.
3
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer.

本文引用的文献

1
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.全基因组关联分析鉴定出亚洲从不吸烟女性肺癌的新易感基因位点。
Nat Genet. 2012 Dec;44(12):1330-5. doi: 10.1038/ng.2456. Epub 2012 Nov 11.
2
X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.X 射线抑制组蛋白去乙酰化酶 1 和 2,上调轴蛋白表达并诱导非小细胞肺癌细胞凋亡。
Radiat Oncol. 2012 Oct 31;7:183. doi: 10.1186/1748-717X-7-183.
3
Genome structural variation discovery and genotyping.
组蛋白去乙酰化酶(HDAC)9:多功能的生物学功能及在人类癌症中的新兴作用。
Cell Oncol (Dordr). 2021 Oct;44(5):997-1017. doi: 10.1007/s13402-021-00626-9. Epub 2021 Jul 27.
4
The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.长链非编码 RNA H19 多态性与肺腺癌临床病理特征表皮生长因子受体表型的关系。
Int J Environ Res Public Health. 2021 Mar 11;18(6):2862. doi: 10.3390/ijerph18062862.
5
Association test using Copy Number Profile Curves (CONCUR) enhances power in rare copy number variant analysis.使用拷贝数谱曲线(CONCUR)的关联分析增强了稀有拷贝数变异分析的效能。
PLoS Comput Biol. 2020 May 4;16(5):e1007797. doi: 10.1371/journal.pcbi.1007797. eCollection 2020 May.
6
The association between HDAC9 gene polymorphisms and stroke risk in the Chinese population: A meta-analysis.HDAC9 基因多态性与中国人群卒中风险的关联:一项荟萃分析。
Sci Rep. 2017 Feb 1;7:41538. doi: 10.1038/srep41538.
7
Association of polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women.多态性与铂类化疗对中国非吸烟女性晚期非小细胞肺癌疗效的相关性
J Thorac Dis. 2016 Sep;8(9):2519-2529. doi: 10.21037/jtd.2016.08.70.
8
Up-regulation of HDAC9 promotes cell proliferation through suppressing p53 transcription in osteosarcoma.组蛋白去乙酰化酶9(HDAC9)的上调通过抑制骨肉瘤中p53转录促进细胞增殖。
Int J Clin Exp Med. 2015 Jul 15;8(7):11818-23. eCollection 2015.
9
Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma.与肺腺癌基因修饰相关的调控单核苷酸多态性的鉴定。
BMC Res Notes. 2015 Mar 24;8:92. doi: 10.1186/s13104-015-1053-8.
基因组结构变异发现与基因分型。
Nat Rev Genet. 2011 May;12(5):363-76. doi: 10.1038/nrg2958. Epub 2011 Mar 1.
4
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.选择性抑制组蛋白去乙酰化酶 6(HDAC6)可诱导 DNA 损伤,并使转化细胞对抗癌药物敏感。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20003-8. doi: 10.1073/pnas.1013754107. Epub 2010 Oct 29.
6
A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.鳞状细胞肺癌中的慢性阻塞性肺疾病相关特征。
Lung Cancer. 2011 May;72(2):177-83. doi: 10.1016/j.lungcan.2010.08.014. Epub 2010 Sep 15.
7
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.组蛋白去乙酰化酶抑制剂诱导 DNA 损伤,正常细胞而非转化细胞可以修复这种损伤。
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14639-44. doi: 10.1073/pnas.1008522107. Epub 2010 Aug 2.
8
Identification of DOK genes as lung tumor suppressors.鉴定 DOK 基因作为肺肿瘤抑制基因。
Nat Genet. 2010 Mar;42(3):216-23. doi: 10.1038/ng.527. Epub 2010 Feb 7.
9
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer.表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)过表达在晚期非小细胞肺癌中的预测价值
Oncogene. 2009 Aug;28 Suppl 1:S32-7. doi: 10.1038/onc.2009.199.
10
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.肺癌的综合基因组分析揭示了EGFR突变肿瘤中双特异性磷酸酶4(DUSP4)的缺失。
Oncogene. 2009 Aug 6;28(31):2773-83. doi: 10.1038/onc.2009.135. Epub 2009 Jun 15.